CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $950,019
- in 1 filing
Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-02 | MOATAZEDI DAVID See Remarks | Sale | −105,108 | $9.04 | $950K | 499,592 |
| 2026-03-20 | Avelar Rui See Remarks | Sale | −3,119 | $4.75 | $15K | 427,423 |
| 2026-03-20 | MOATAZEDI DAVID See Remarks | Sale 10b5-1 | −13,669 | $4.75 | $65K | 604,700 |
| 2026-03-17 | MOATAZEDI DAVID See Remarks | Sale 10b5-1 | −116,720 | $4.89 | $571K | 618,369 |
| 2026-03-17 | Avelar Rui See Remarks | Sale 10b5-1 | −29,996 | $4.89 | $147K | 430,542 |
| 2026-03-16 | MOATAZEDI DAVID See Remarks | Option exercise 10b5-1 | +67,489 | 735,089 | ||
| 2026-03-16 | MOATAZEDI DAVID See Remarks | Option exercise · Performance Restricted Stock Units 10b5-1 | −67,489 | 67,488 | ||
| 2026-03-16 | Avelar Rui See Remarks | Option exercise 10b5-1 | +8,804 | 460,538 | ||
| 2026-03-16 | Avelar Rui See Remarks | Option exercise · Performance Restricted Stock Units 10b5-1 | −8,804 | 8,802 | ||
| 2026-02-17 | Parschauer Karah Herdman Director | Grant or award | +45,559 | 77,742 | ||
| 2026-02-17 | Stewart Brady Director | Grant or award | +45,559 | 134,188 | ||
| 2026-02-17 | Mitchell Tatjana Chief Financial Officer | Grant or award | +121,489 | 226,092 | ||
| 2026-02-17 | Mitchell Tatjana Chief Financial Officer | Grant or award · Performance Restricted Stock Units | +121,489 | 121,489 | ||
| 2026-02-17 | Mitchell Tatjana Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +177,471 | 177,471 | ||
| 2026-02-17 | White Albert G III Director | Grant or award | +45,559 | 95,937 | ||
| 2026-02-17 | MOATAZEDI DAVID See Remarks | Grant or award | +313,212 | 667,600 | ||
| 2026-02-17 | MOATAZEDI DAVID See Remarks | Grant or award · Performance Restricted Stock Units | +626,424 | 626,424 | ||
| 2026-02-17 | MOATAZEDI DAVID See Remarks | Grant or award · Stock Option (Right to Buy) | +457,541 | 457,541 | ||
| 2026-02-17 | Malik Vikram Director | Grant or award | +45,559 | 321,109 | ||
| 2026-02-17 | Avelar Rui See Remarks | Grant or award | +94,913 | 451,734 |
Page 1 of 16 · 303 trades